For instance, robust MYCN binding was mapped across the SLC1A5 (ASCT2) locus, which encodes a known regulator of glutamine metabolism, a key feature of neuroblastoma tumorigenesis [71,72] (Figure 2A upper panel). Here, MYCN is linked to neuroblastoma.